Pay in 4 interest-free payments of $27.00 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Pomalidomide4PEG3amine
Rofecoxib is a nonsteroidal anti-inflammatory drug (NSAID) that has now been withdrawn over safety concerns
CAS Number: 193273-69-7
Activation of EPAC1/2 is essential for osteoclast formation by modulating NFκB nuclear translocation and actin cytoskeleton rearrangements
and this is accompanied by 59% inhibition of tumor growth
TAK-875 er-5 Pomalidomide4PEG3amineTAK 875, is a potent, selective, and orally bioavailable GPR40 agonist, with a pharmacokinetic profile enabling long acting drug efficacy. TAK 875 showed potent plasma glucose lowering action and insulinotropic action during an oral glucose tolerance test in female Wistar fatty rats with impaired glucose tolerance. TAK 875 is currently in clinical trials for the treatment of type 2 diabetes mellitus. Product information CAS Number: 1000413 72 8
US$ 38.00
US$ 131.60
US$ 38.00
US$ 40.11
US$ 70.00
US$ 82.00
US$ 30.00